Atea Pharmaceuticals Inc. (AVIR)
NASDAQ · Healthcare
Atea Pharmaceuticals Inc. Operating Income 2020–2021
Atea Pharmaceuticals Inc. annual/quarterly operating income history and growth rate from 2020 to 2021. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Atea Pharmaceuticals Inc. operating income for the quarter ending September 30, 2021 was -22.1 M.
- Atea Pharmaceuticals Inc. annual operating income for 2021 was 138.4 M, a 1354.55% decrease from 2020.
- Atea Pharmaceuticals Inc. annual operating income for 2020 was -11.0 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Atea Pharmaceuticals Inc. Operating Income — FAQ
Atea Pharmaceuticals Inc. (AVIR) operating income over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Atea Pharmaceuticals Inc.'s operating income?
Atea Pharmaceuticals Inc. (AVIR) reported operating income of $138M for fiscal 2021.
Where can I see AVIR's operating income history?
The chart and table above show Atea Pharmaceuticals Inc.'s operating income by year and by quarter, including the growth rate.